📰 Trial Program News
Page 21 - Trial Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Trial Program. Real-time updates on events, politics, business and more.
May 21, 2023
Dupixent is the first and only investigational biologic for COPD that has demonstrated a significant reduction in moderate or severe acute exacerbations by 30% compared to placebo Dupixent is the... | June 11, 2023
May 21, 2023
Dupixent® late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine Dupixent is the first and only investigational biologic for... | June 11, 2023
May 3, 2023
Scalable Supply of CTx-1301 Ready to be Produced with Cingulate on Track to Meet Previously Announced Clinical Timelines for Phase 3 Trial ProgramKANSAS CITY, Kan., May 03, 2023 -- Cingulate Inc. ,... | May 3, 2023
May 3, 2023
Cingulate Announces Successful Transfer of CTx-1301 Proprietary PTR™ Manufacturing Processes to Societal CDMO Scalable Supply of CTx-1301 Ready to be... | May 3, 2023
February 27, 2023
XRP price is enticing investors to take a speculative buy as recent innovations could lead to an out-of-nowhere style crypto rally. Still, the technic
November 5, 2022
/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced late-breaking presentations of updated results from two positive pivotal trials...
September 30, 2022
/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the first presentations of positive detailed results from two pivotal trials...
September 30, 2022
/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the first presentations of positive detailed results from two pivotal trials...
September 16, 2022
Flash Motors Limited (Flash), an electric mobility solutions company, has announced that former 100-metre world record holder Asafa Powell has joined its leadership team. This week Flash launched its first TV commercial featuring Powell, who